Astrazeneca Pharma India Ltd.

Financial

	Astrazeneca Pharma I	Wockhardt	Gland Pharma
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	18.6 %	10.6 %	n/a
R&D as a % of Total Sales	0.0	4.2 %	4.3 %
Financials
5 yr Average ROE	18.37 %	-3.81 %	14.74 %
5yr average Equity Multiplier	1.94	2.26	1.13
5yr Average Asset Turnover Ratio	0.94	0.39	0.53
5yr Avg Net Profit Margin	10.03 %	-4.46 %	24.17 %
Price to Book	33.37	6.77	2.77
P/E	233.79	0.0	34.6
5yr Avg Cash Conversion Cycle	-36.14 Days	-118.47 Days	72.51 Days
Inventory Days	64.11 Days	68.12 Days	117.52 Days
Days Receivable	36.53 Days	71.63 Days	78.29 Days
Days Payable	208.62 Days	260.3 Days	103.04 Days
5yr Average Interest Coverage Ratio	140.96	-0.67	205.64
5yr Avg ROCE	23.99 %	-1.45 %	19.61 %
5yr Avg Operating Profit Margin	14.51 %	3.11 %	32.0 %
5 yr average Debt to Equity	0.0	0.71	0.01
5yr CAGR Net Profit	17.47 %	46.24 %	-0.01 %
5yr Average Return on Assets	9.52 %	-1.84 %	13.18 %
Shareholdings
Promoter Holding	75.0 %	49.09 %	51.83 %
Share Pledged by Promoters	0.0	18.24 %	0.0
Change in Promoter Holding (3 Yrs)	0.0	-18.04 %	-6.17 %
Change in Mutual Fund Holding (3 Yrs)	3.46 %	7.53 %	19.94 %

Business

	Astrazeneca Pharma I	Wockhardt	Gland Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 93.06 Clinical Trial 6.94 Pharmaceuticals 0 Injectables 0	Product Wise Break-Up Injectables 0 Pharmaceutical 0 Clinical Trial 0 Pharmaceutical 100.0	Product Wise Break-Up Injectables 0 Pharmaceutical 0 Clinical Trial 0 Pharmaceutical 100.0
Location Wise Break-Up	Location Wise Break-Up India 93.61 Rest of the World 6.39 Europe 0 USA 0 Canada, Australia & New Zealand 0 Australia 0 Canada 0	Location Wise Break-Up Rest of the World 10.21 Canada, Australia & New Zealand 0 Europe 24.69 India 15.72 Canada 0 USA 3.45 Australia 0 Others 45.93	Location Wise Break-Up Rest of the World 0 Canada, Australia & New Zealand 3.32 Europe 19.12 India 4.06 Canada 0 USA 52.69 Australia 0 Others 20.81
Therapeutic Area Break-Up	Therapeutic Area Break-Up Oncology 62.3 Cardiac Science 24.4 Anti - Diabetes 9.8 Respiratory Systems 3.5 Gastrointestinal 0 Infection 0	-	-
Dosage Form Break-Up	Dosage Form Break-Up Tablet 67.23 Injectable 24.44 Clinical Trial 6.94 Inhalation 1.39	-	-